Surrozen Inc (SRZN)
Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Exicure, Inc. - Exicure, Inc. Reports Third Quarter 2025 Financial Results
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Savara Inc.(SVRA) Shareholders
Exicure, Inc. Reports Third Quarter 2025 Financial Results
Best Touch Screen Laptops (2026)
Best Digital Cameras on Amazon (2026)
Best Apple Watches for 2026